Laura Clague

Insider Reports History

Entity
Individual
Location
370 Park Ranch Place, Escondido, California
Signature
/s/ Laura Clague by Agnieszka Gallagher, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laura Clague:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Genasys Inc. Director Common Stock 284 K $526 K $1.85 Apr 27, 2022 Direct
Travere Therapeutics, Inc. Chief Financial Officer Common Stock 35.7 K $319 K $8.96 May 11, 2022 Direct
STANDARD BIOTOOLS INC. Director Common Stock 105 K $266 K $2.54 Jun 14, 2023 Direct
STANDARD BIOTOOLS INC. Director Stock Option (Right to Buy) 35.4 K $132 K $3.74 Jun 14, 2023 Direct
Genasys Inc. Director Common Stock 2 K $3.7 K $1.85 Apr 27, 2022 spouse
Genasys Inc. Director Stock Option 0 Apr 27, 2022 Direct

Insider Reports Filed by Laura Clague

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LAB STANDARD BIOTOOLS INC. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
LAB STANDARD BIOTOOLS INC. Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
TVTX Travere Therapeutics, Inc. May 10, 2022 2 -$47.3 K 4 May 12, 2022 Chief Financial Officer
GNSS Genasys Inc. Apr 27, 2022 2 $66.5 K 4 Apr 27, 2022 Director
GNSS Genasys Inc. Mar 15, 2022 1 $0 4 Mar 17, 2022 Director
GNSS Genasys Inc. Feb 23, 2022 3 $132 4 Feb 24, 2022 Director
TVTX Travere Therapeutics, Inc. Jan 31, 2022 5 -$33.9 K 4 Feb 2, 2022 Chief Financial Officer
TVTX Travere Therapeutics, Inc. Jan 24, 2022 1 -$51.5 K 4 Jan 26, 2022 Chief Financial Officer
TVTX Travere Therapeutics, Inc. Jan 10, 2022 2 -$206 K 4 Jan 12, 2022 Chief Financial Officer
TVTX Travere Therapeutics, Inc. Aug 13, 2021 2 -$24.1 K 4 Aug 17, 2021 Chief Financial Officer
LAB FLUIDIGM CORP May 25, 2021 2 $0 4 May 27, 2021 Director
TVTX Travere Therapeutics, Inc. May 11, 2021 2 -$77.2 K 4 May 13, 2021 Chief Financial Officer